(Q34139624)

31 July 2017

1 reference

title

Genetic models for CNS inflammation (English)

1 reference

31 July 2017

0 references

Owens T

1

1 reference

31 July 2017

Wekerle H

series ordinal

2

1 reference

31 July 2017

Antel J

series ordinal

3

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

31 July 2017

1 reference

31 July 2017

7

1 reference

31 July 2017

161-166

1 reference

31 July 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/84603

31 July 2017

0 references

cites work

Walking through the forest of transgenic models of human disease

1 reference

7 January 2021

B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice

1 reference

7 January 2021

Tumor necrosis factor identified in multiple sclerosis brain

1 reference

7 January 2021

Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions

1 reference

7 January 2021

Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor alpha and tumor necrosis factor beta

1 reference

7 January 2021

Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis

1 reference

7 January 2021

Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor-alpha in the central nervous system

1 reference

7 January 2021

TNF-alpha transgenic and knockout models of CNS inflammation and degeneration

1 reference

7 January 2021

Late-onset chronic inflammatory encephalopathy in immune-competent and severe combined immune-deficient (SCID) mice with astrocyte-targeted expression of tumor necrosis factor

1 reference

7 January 2021

Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy.

1 reference

7 January 2021

Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1

1 reference

7 January 2021

Tumor necrosis factor: a master-regulator of leukocyte movement

1 reference

7 January 2021

Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors

1 reference

7 January 2021

TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination.

1 reference

7 January 2021

Cytokines and antibodies in myelin oligodendrocyte glycoprotein-induced experimental allergic encephalomyelitis

1 reference

7 January 2021

Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice

1 reference

7 January 2021

Cytokine gene expression in cells derived from CSF of multiple sclerosis patients

1 reference

7 January 2021

Lymphokines and immunoregulatory molecules in subacute sclerosing panencephalitis

1 reference

7 January 2021

Inflammatory cytokines in the brain: does the CNS shape immune responses?

1 reference

7 January 2021

The effects of interferon-gamma on the central nervous system.

1 reference

7 January 2021

Immune modulation within the brain: recruitment of inflammatory cells and increased major histocompatibility antigen expression following intracerebral injection of interferon-gamma.

1 reference

7 January 2021

Direct injection of cytokines into the spinal cord causes autoimmune encephalomyelitis-like inflammation

1 reference

7 January 2021

Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in Lewis rats

1 reference

7 January 2021

Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development

1 reference

7 January 2021

Primary demyelination in transgenic mice expressing interferon-gamma

1 reference

7 January 2021

Interferon-gamma in progression to chronic demyelination and neurological deficit following acute EAE

1 reference

7 January 2021

IFNgamma enhances microglial reactions to hippocampal axonal degeneration

1 reference

7 January 2021

Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes.

1 reference

7 January 2021

Major histocompatibility complex Class I expression in oligodendrocytes induces hypomyelination in transgenic mice

1 reference

7 January 2021

Major histocompatibility complex heavy chain accumulation in the endoplasmic reticulum of oligodendrocytes results in myelin abnormalities

1 reference

7 January 2021

Interferon-gamma modulates human oligodendrocyte susceptibility to Fas-mediated apoptosis

1 reference

7 January 2021

IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines.

1 reference

7 January 2021

Interferon-gamma confers resistance to experimental allergic encephalomyelitis.

1 reference

7 January 2021

Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis

1 reference

7 January 2021

Effect of anti-interferon-gamma and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse.

1 reference

7 January 2021

Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines

1 reference

7 January 2021

Neutrophil infiltration, glial reaction, and neurological disease in transgenic mice expressing the chemokine N51/KC in oligodendrocytes

1 reference

7 January 2021

CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis

1 reference

7 January 2021

Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1alpha or its CCR5 receptor

1 reference

7 January 2021

Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis

1 reference

7 January 2021

Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery

1 reference

7 January 2021

Specific immunotherapy: one size does not fit all.

1 reference

7 January 2021

Late complications of immune deviation therapy in a nonhuman primate

1 reference

7 January 2021

Astroglial overproduction of TGF-beta 1 enhances inflammatory central nervous system disease in transgenic mice .

1 reference

7 January 2021

Experimental allergic encephalomyelitis: neutralizing antibody to TGF beta 1 enhances the clinical severity of the disease.

1 reference

7 January 2021

Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice

1 reference

7 January 2021

Transgenic models to study the actions of cytokines in the central nervous system

1 reference

7 January 2021

IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis.

1 reference

7 January 2021

An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease.

1 reference

7 January 2021

Immunologic therapy of multiple sclerosis

1 reference

7 January 2021

Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system

1 reference

7 January 2021

Gamma-interferon induction in patients with chronic progressive MS

1 reference

7 January 2021

Intravenous immunoglobulin induces interferon-gamma and interleukin-6 in vivo

1 reference

7 January 2021

Experimental autoimmune encephalomyelitis: immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors

1 reference

7 January 2021

[Multiple sclerosis. Current review of failed and discontinued clinical trials of drug treatment]

1 reference

7 January 2021

The temporal importance of TNFalpha expression in the development of diabetes

1 reference

7 January 2021

Protective effect of the interleukin-1 receptor antagonist (IL-1ra) on experimental allergic encephalomyelitis in rats

1 reference

7 January 2021

Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12.

1 reference

7 January 2021

Differential induction of interleukin-12, interleukin-18, and interleukin-1beta converting enzyme mRNA in experimental autoimmune encephalomyelitis of the Lewis rat.

1 reference

7 January 2021

C10 is a novel chemokine expressed in experimental inflammatory demyelinating disorders that promotes recruitment of macrophages to the central nervous system

1 reference

7 January 2021

Identifiers

DOI

10.1038/84603

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference